Other OTC - Delayed Quote USD

SANUWAVE Health, Inc. (SNWV)

0.0187

-0.0043

(-18.61%)

At close: April 25 at 11:35 AM EDT

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history.Q1 2024 revenue increased between 51% and 56% compared to Q1 2...

NewMediaWire 15 days ago

SNWV
-18.61%
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVEEDEN PRAIRIE, MN - (NewMediaWire) - April 01, 2024 - SANUWAVE Health, Inc. (the...

NewMediaWire 24 days ago

SNWV
-18.61%
SANUWAVE Announces Record Q4 and FY2023 Revenue

SANUWAVE Announces Record Q4 and FY2023 Revenue

NewMediaWire last month

SNWV
-18.61%
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

EDEN PRAIRIE, MN - (NewMediaWire) - March 20, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024...

NewMediaWire last month

SNWV
-18.61%
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 "for" and 5,221,765 "against" with 71,525 abstaining70.5% of all shares eligible to...

NewMediaWire 2 months ago

SNWV
-18.61%
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

EDEN PRAIRIE, MN - (NewMediaWire) - January 22, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting...

NewMediaWire 3 months ago

SNWV
-18.61%
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quarter of 2023. Preliminary FY 2023 revenue range was $20.0 million to $20.2 million, an increase of 19% to 20% year over year. This represents record annual revenues for the Company. UltraMist revenues for Q4 2023

GlobeNewswire 3 months ago

SNWV
-18.61%
SANUWAVE Announces Q3 2023 Financial Results

EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results. For the three months ended September 30, 2023: Revenue for the three months ended September 30, 2023 totaled $5.0 million, an increase of 19%, as compared to $4.2 million for the same period of 2022. This growth falls within the previously pro

GlobeNewswire 5 months ago

SNWV
-18.61%
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Listening: 1-877-407-0784 or 1-201-689-8560 Conference ID number : 13742652 OR click the Call me™ link for instant telep

GlobeNewswire 5 months ago

SNWV
-18.61%
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist Revenues (systems and consumables) Increased in Excess of 25% Year On Year and by Greater Than 10% vs Q2 2023 EDEN PRAIRIE, MN, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care

GlobeNewswire 6 months ago

SNWV
-18.61%
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

· SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”. · The combined company expects to receive approximately $13.0 million of gross proceeds at closing, including $12.0 million from non-redeeming holders of SEPA’s Class A common stock and other PIPE investors, and $1.0 million from the SPAC sponsor converting a loa

GlobeNewswire 7 months ago

SEPA

SEPAU

SNWV
-18.61%
SANUWAVE Announces Q2 2023 Financial Results

EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 2nd quarter 2023 results. For the three months ended June 30, 2023: Revenue for the three months ended June 30, 2023 totaled $4.7 million, an increase of 20%, as compared to $3.9 million for the same period of 2022. This growth falls within the previously provided guidance range of 15-25%

GlobeNewswire 8 months ago

SNWV
-18.61%
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Listening: 1-877-407-0784 or 1-201-689-8560 Conference ID number: 13740603 OR click the Call me™ link for in

GlobeNewswire 8 months ago

SNWV
-18.61%
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.

Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist line of directed energy wound care products. Long-term agreement to develop and expand the market for SANUWAVE “Energy First” treatments. EDEN PRAIRIE, MN, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB:SNWV), a leading provider of next-generation FDA-approved wound care products, today announced a

GlobeNewswire 8 months ago

SNWV
-18.61%
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President

Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person contract manufacturing organization EDEN PRAIRIE, MN, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the hiring of Andrew Walko as its new President. Walko brings deep experi

GlobeNewswire 8 months ago

SNWV
-18.61%
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results indicate 16-21% growth rate over Q2 2022, consistent with guidance provided in the Q1 2023 earnings release EDEN PRAIRIE, MN, July 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the second quarter of 2023

GlobeNewswire 9 months ago

SNWV
-18.61%
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer

Frank Brings 29 Years of Experience in Life Sciences, Technology, and Capital Markets Kevin Richardson to Remain at SANUWAVE as Chief Strategic Officer and as a Member of the Board of Directors EDEN PRAIRIE, MN, May 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB:SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that its Board of Directors has appointed Morgan Frank as Chief Executive Officer.

GlobeNewswire 10 months ago

SNWV
-18.61%
SANUWAVE Announces Q1 2023 Financial Results

EDEN PRAIRIE, MN, May 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 1st quarter 2023 results. For the three-months ended March 31, 2023: Revenues increased 18% to $3.8 million for Q1 2023 versus $3.2 million for the same period last year. This growth falls within the guidance range of 14-20%, provided on the prior conference call.UltraMist® systems sold increased 12% to

GlobeNewswire 11 months ago

SNWV
-18.61%
SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update

EDEN PRAIRIE, MN, May 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, May 12, 2023, at 9:00AM (EDT) to discuss a financial update and recent strategic initiatives. Telephone access to the call will be available by dialing the following numbers: Participant Listening: 1-877-407-0784 or 1-201-689-8560 OR click the Call me™ link for instant telephone access to

GlobeNewswire 11 months ago

SNWV
-18.61%
SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference. The event will be co-located with the Diabetic Limb Salvage (DLS) conference from April 26-30, 2023 in National Harbor, MD. The SAWC Spring | WHS conference is the prem

GlobeNewswire 11 months ago

SNWV
-18.61%

Performance Overview

Return	SNWV	S&P 500
YTD	+44.00%	+5.84%
1-Year	-34.32%	+22.03%
3-Year	-88.99%	+20.77%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

SANUWAVE Health, Inc. (SNWV)

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

SANUWAVE Announces Record Q4 and FY2023 Revenue

SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

SANUWAVE Announces Q3 2023 Financial Results

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

SANUWAVE Announces Q2 2023 Financial Results

SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.

SANUWAVE Health Appoints Industry Veteran Andrew Walko as President

SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer

SANUWAVE Announces Q1 2023 Financial Results

SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

Performance Overview